Track Damora Therapeutics's receivables ($840K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Damora Therapeutics (DMRA) currently reports a receivables of $840K as of September 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Damora Therapeutics's receivables history and peer comparisons.
Damora Therapeutics's receivables changed from $0 to $840K (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Damora Therapeutics reported $840K in receivables as of September 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $840K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Damora Therapeutics, and consider following DMRA for alerts when major investors trade the stock.
Damora Therapeutics is classified in the Healthcare sector. On receivables, it currently shows $840K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DMRA with unrelated industries.